Supportive Care Therapies: Complexities Made Simple
Includes a Live Event on 09/22/2021 at 1:00 PM (EDT)
Medical Education Grant: Fresenius Kabi
Infusion nurses are considered experts in caring for patients receiving high-risk intravenous therapies such as chemotherapy and parenteral nutrition (PN). Due to the invasive nature and risks associated with infusion therapy, developing protocols with clear direction to support evidence-based clinical practice is critical to ensure that these complex therapies are safely administered. Involvement of infection prevention strategies while managing various infusion pump setups with different IV lines and filters make administration of PN even more complex. This presentation will further address the key elements of the 2021 INS Standards of Practice for safe infusion of complex parenteral nutrition therapies to achieve optimal patient outcomes. FDA–approved biological products provide a pathway to provide more treatment options and increase access to lifesaving medications. During the second half of this webinar, we will discuss the reasons for biosimilars, the FDA approval process, and the key comparative elements of biosimilars versus innovator products. In particular, the presentation will focus on the pegfilgrastim biosimilar products to enhance confidence in and understanding of their efficacy and suitability for oncology patients.
Learning Objectives: At the conclusion of this presentation, learners will be able to:
· Discuss updates and key elements of the 2021 INS Standards of Practice pertaining to parenteral nutrition including infection prevention and discontinuing/restarting parenteral nutrition
· Determine PN administration considerations for various infusion setups such as administration sets, pump setups, and filters
· Identify safe PN formulations
· Define biosimilars and describe their development and FDA approval to educate your patients
· Recognize pegfilgrastim biosimilars considerations in oncology supportive care for prevention of infection manifested by febrile neutropenia
Margaret McGuinness, PharmD, BCOP
Director of Pharmacy and Research Services
Margaret McGuinness is currently the director of pharmacy and research services at Compass Oncology, where she has practiced for almost 20 years. She previously worked in academia and oncology practice at the Portland VA and Oregon State University. In the past 2 years, she has led introduction and integration of biosimilars into practice. She has more than 30 years of oncology clinical practice, pharmacy and health care leadership and strategy through professional work, and experience in professional organizations including president of state and local organizations. She has had academic and clinical training and practice in the United States, New Zealand, Australia, and Great Britain.
Saralynn Tuttle, PharmD
Pharmacy Operations Coordinator
Broward Health Coral Spring
Saralynn Tuttle is a graduate of Nova Southeastern University with a doctorate of pharmacy. She has over 20 years of experience as a clinical pharmacist. The majority of her career was dedicated to the clinical monitoring and management of parenteral nutrition in the neonatal population at the Salah Foundation Children's Hospital. In 2014, she accepted a leadership role as the clinical coordinator of pediatric pharmacy services, and in 2018, she accepted the role of the medication safety and quality coordinator for the Joe DiMaggio Children's Hospital. She currently works as the pharmacy operations coordinator at Broward Health Coral Springs.
CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: September 22, 2024
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.